An Open-label, Single-centre, Randomised, 2-period Cross-over Study to Assess the Efficacy and Safety of 24-hour Closed-loop Glucose Control in Comparison With Conventional Subcutaneous Insulin Pump Treatment Simulating Non-compliant Behaviours in Adolescents With Type 1 Diabetes
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 29 Oct 2012 Accrual to date is 116% according to United Kingdom Clinical Research Network.
- 15 Oct 2012 New source identified and integrated (United Kingdom Clinical Research Network: 11447).
- 03 Jul 2012 New trial record